James M. Chen
37Patents
17h-index
65Co-inventors
80Inventor score
Filing activity: Feb 4, 1999 → Jun 19, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6934639B1 | Methods for designing agents that interact with MMP-13 | Chemistry; Metallurgy | 97 | Expired |
| US7842672B2 | Phosphonate inhibitors of HCV | Human Necessities | 93 | Active |
| US7452901B2 | Anti-cancer phosphonate analogs | Chemistry; Metallurgy | 69 | Expired |
| US7645747B2 | Therapeutic phosphonate compounds | Chemistry; Metallurgy | 57 | Expired |
| US8324179B2 | Nucleoside analogs for antiviral treatment | Chemistry; Metallurgy | 54 | Active |
| US8022083B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 44 | Active |
| US8871785B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 33 | Active |
| US7462608B2 | Non nucleoside reverse transcriptase inhibitors | Physics | 29 | Expired |
| US7417055B2 | Kinase inhibitory phosphonate analogs | Chemistry; Metallurgy | 28 | Expired |
| US6225311A | Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors | Chemistry; Metallurgy | 28 | Expired |
| US9139604B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 26 | Active |
| US7407965B2 | Phosphonate analogs for treating metabolic diseases | Human Necessities | 26 | Expired |
| US7429565B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 24 | Expired |
| US7470724B2 | Phosphonate compounds having immuno-modulatory activity | Human Necessities | 23 | Expired |
| US7432261B2 | Anti-inflammatory phosphonate compounds | Chemistry; Metallurgy | 23 | Expired |
| US7427636B2 | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds | Chemistry; Metallurgy | 21 | Expired |
| US6313123A | Acetylenic sulfonamide thiol tace inhibitors | Chemistry; Metallurgy | 20 | Expired |
| US6340691B1 | Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors | Chemistry; Metallurgy | 17 | Expired |
| US6326516A | Acetylenic .beta.-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors | Chemistry; Metallurgy | 14 | Expired |
| US7253180B2 | Pre-organized tricyclic integrase inhibitor compounds | Chemistry; Metallurgy | 12 | Expired |
| US7741345B2 | AZA-peptide protease inhibitors | Chemistry; Metallurgy | 12 | Active |
| US7427624B2 | Purine nucleoside phosphorylase inhibitory phosphonate compounds | Human Necessities | 11 | Expired |
| US6277885A | Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors | Chemistry; Metallurgy | 10 | Expired |
| US6200996A | Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors | Human Necessities | 9 | Expired |
| US6358980B1 | Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors | Chemistry; Metallurgy | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.